Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 9.320 CNY | -0.85% |
|
-4.41% | -20.95% |
| Market Cap | 12.37B 1.85B 1.64B 1.52B 1.39B 2.61B 175B 2.66B 18.3B 7.18B 91.54B 6.94B 6.79B 292B | P/E 2026 * |
18.6x | P/E 2027 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 10.03B 1.5B 1.33B 1.23B 1.12B 2.12B 142B 2.15B 14.84B 5.82B 74.24B 5.63B 5.51B 237B | EV / Sales 2026 * |
1.96x | EV / Sales 2027 * | 2.38x |
| Free-Float |
14.94% | Yield 2026 * |
0.64% | Yield 2027 * | 0.75% |
| 1 day | -0.85% | ||
| 1 week | -4.41% | ||
| Current month | -5.38% | ||
| 1 month | -0.64% | ||
| 3 months | -7.81% | ||
| 6 months | -18.53% | ||
| Current year | -20.95% |
| 1 week | 9.23 |  | 9.94 |
| 1 month | 9.23 | | 10 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 12.68 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 21/04/1998 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 21/04/1998 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 21/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 21/04/1998 |
Li Li
CHM | Chairman | 62 | 21/04/1998 |
Yu Shan
BRD | Director/Board Member | 65 | 21/04/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/05/23 | Sell | 11,200 | 0.0009% | |||
| 26/05/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | -4.41% | -21.08% | -25.62% | 1.86B | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,116B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 610B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 501B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 235B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 195B | |
| Average | -0.07% | +4.32% | +29.56% | +52.70% | 393.16B | |
| Weighted average by Cap. | +0.29% | +4.93% | +39.13% | +71.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.1B 763M 678M 628M 572M 1.08B 72.4B 1.1B 7.55B 2.96B 37.78B 2.86B 2.8B 120B | 5.62B 839M 746M 692M 629M 1.19B 79.66B 1.21B 8.31B 3.26B 41.57B 3.15B 3.08B 133B |
| Net income | 731M 109M 97.06M 89.96M 81.85M 154M 10.36B 157M 1.08B 424M 5.41B 410M 401M 17.24B | 874M 131M 116M 108M 97.89M 185M 12.39B 188M 1.29B 507M 6.47B 490M 480M 20.62B |
| Net Debt | -2.34B -349M -310M -288M -262M -494M -33.15B -502M -3.46B -1.36B -17.3B -1.31B -1.28B -55.15B | 1B 150M 133M 124M 112M 212M 14.24B 216M 1.49B 582M 7.43B 563M 551M 23.68B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | CN¥9.320 | -0.85% | 3,601,520 |
| 15/10/26 | CN¥9.400 | -0.74% | 2,592,000 |
| 14/10/26 | CN¥9.470 | -1.56% | 3,096,540 |
| 13/10/26 | CN¥9.620 | -1.13% | 4,053,160 |
| 12/10/26 | CN¥9.730 | -1.62% | 3,749,140 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
